Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction.
Cancer Immunol Immunother. 2022 Dec;71(12):2881-2898. doi: 10.1007/s00262-022-03197-2. Epub 2022 Apr 23.
Cancer Immunol Immunother. 2022.
PMID: 35460379
Free PMC article.
Correction to: Tcf‑1 protects anti‑tumor TCR‑engineered CD8+ T‑cells from GzmB mediated self‑destruction.
Zangari B, Tsuji T, Matsuzaki J, Mohammadpour H, Eppolito C, Battaglia S, Ito F, Chodon T, Koya R, Robert McGray AJ, Odunsi K.
Zangari B, et al.
Cancer Immunol Immunother. 2022 Dec;71(12):2899. doi: 10.1007/s00262-022-03233-1.
Cancer Immunol Immunother. 2022.
PMID: 35666273
Free PMC article.
No abstract available.
Item in Clipboard
Phosphinophosphonates and Their Tris-pivaloyloxymethyl Prodrugs Reveal a Negatively Cooperative Butyrophilin Activation Mechanism.
Shippy RR, Lin X, Agabiti SS, Li J, Zangari BM, Foust BJ, Poe MM, Hsiao CC, Vinogradova O, Wiemer DF, Wiemer AJ.
Shippy RR, et al. Among authors: zangari bm.
J Med Chem. 2017 Mar 23;60(6):2373-2382. doi: 10.1021/acs.jmedchem.6b00965. Epub 2017 Mar 1.
J Med Chem. 2017.
PMID: 28218845
Free PMC article.
Item in Clipboard
Cite
Cite